Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	115.78	100.83	46.73
Graham Fair Price	41.54	4.09	2.89
PEG	-70.77	-0.02	0.08
Price/Book	-36.04	0.36	0.56
Price/Cash Flow	-97.97	6.62	-326.07
Prices/Earnings	69.52	-2.25	-7.38
Price/Sales	-31.27	0.27	0.40
Price/FCF	-97.97	6.62	-326.07
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.50	0.38	0.36
Operating Margin	-23.21	-0.01	0.01
ROA	-129.83	< 0.005	< 0.005
ROE	-0.02	-0.04	-109.82
ROIC	< 0.005	< 0.005	-10.96
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	< 0.005	-552.68
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	1.02	-1.70	66.88
EPS QOQ	0.98	-1.02	4.27
FCF QOQ	0.93	31.90	3340.18
Revenue QOQ	0.12	-0.09	-28.08
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	57.68	64.49	11.81
Days Sales Outstanding (DSO)	2.73	2.48	-9.41
Inventory Turnover	1.56	1.40	-10.56
Debt/Capitalization	0.62	0.62	0.39
Quick Ratio	0.17	0.12	-27.71
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	4.41	4.31	-2.29
Cash	0.52	0.33	-35.69
Capex	-0.18	-0.12	33.76
Free Cash Flow	< 0.005	0.23	2976.66
Revenue	6.23	5.67	-9.07
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.86	0.85	-1.13
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	37.98	88.08	131.94
Naive Interpretation	Member

06 - Financial Health · Bad

Rating